Gene Editing, Gene Therapy, and the Eye as a Gateway
Jennifer Joe, MD
CEO, Medstro, Editor-In-Chief, MedTech Boston
Katrine Bosley
CEO, Editas Medicine
Eric Pierce, MD, PhD
Director, Retinal Degenerations Service, Massachusetts Eye and Ear; Solman and Libe Friedman Associate Professor of Ophthalmology, Harvard Medical School
Philip Gregory, D. Phil
Senior Vice President, Research and CSO, Sangamo BioSciences
David Meeker, MD
CEO, Genzyme
MS Transformed: Harnessing Biology and Inflammation
Mallika Marshall, MD
Medical Reporter, WBZ-TV Boston
Tim Coetzee, PhD
Chief Advocacy, Services, and Research Officer, National Multiple Sclerosis Society
Al Sandrock, MD, PhD
Group Senior Vice President, Chief Medical Officer, Biogen
Howard Weiner, MD
Founder and Director, Partners Multiple Sclerosis Center; Robert L. Kroc Professor of Neurology, Harvard Medical School
Michael Panzara, MD
Group Vice President, Therapeutic Area Head, Multiple Sclerosis and Neurology, Genzyme
